M&A Deal Summary

Moberg Pharma Acquires Alterna

On November 28, 2012, Moberg Pharma acquired medical products company Alterna from Altaris for 133M SEK

Acquisition Highlights
  • This is Moberg Pharma’s 1st transaction in the Medical Products sector.
  • This is Moberg Pharma’s 0th largest (disclosed) transaction.
  • This is Moberg Pharma’s 1st transaction in the United States.
  • This is Moberg Pharma’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2012-11-28
Target Alterna
Sector Medical Products
Buyer(s) Moberg Pharma
Sellers(s) Altaris
Deal Type Add-on Acquisition
Deal Value 133M SEK

Target

Alterna

Cedar Knolls, New Jersey, United States
Alterna LLC is an owner and marketer of therapeutic, over-the-counter (OTC) medicines and personal product brands. Alterna mission is to provide high quality, over the counter healthcare products to consumers and establish strong brands that increase profit for retailers.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Moberg Pharma

Bromma, Sweden
Category Company
Founded 2006
Sector Medical Products
Employees9
Revenue 439M SEK (2018)
DESCRIPTION

Moberg Pharma is a Swedish pharmaceutical company with direct sales through its own sales organization in the US and sales through distributors in more than 35 countries. The company’s product portfolio includes topical products for the treatment of skin disorders and pain under the brands Kerasal®, Jointflex®, Kerasal Nail® and Kaprolac®. Kerasal Nail® (Nalox™ in many markets) is the leading product for the treatment of nail disorders in the Nordic market. Moberg Pharma was founded in 2006 and is based in Bromma, Sweden.

DEAL STATS #
Overall 1 of 7
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 1 of 1
State (New Jersey) 1 of 4
Country (United States) 1 of 7
Year (2012) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-06 Domeboro

Cedar Knolls, New Jersey, United States

Domeboro is a provider of topical astringent used for relieving itch and minor skin irritations.

Buy -

Seller(S) 1

SELLER

Altaris

New York City, New York, United States
Category Private Equity Firm
Founded 2003
PE ASSETS 10.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Altaris is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris was formed in 2004 and is based in New York, New York.

DEAL STATS #
Overall 7 of 24
Sector (Medical Products) 2 of 8
Type (Add-on Acquisition) 4 of 10
State (New Jersey) 1 of 2
Country (United States) 6 of 22
Year (2012) 2 of 2
Size (of disclosed) 8 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-15 U.S. HealthWorks

Valencia, California, United States

U.S. HealthWorks is a provider of occupational healthcare services in the United States. The Company offers solutions for employers that are seeking to control workers’ compensation costs, minimize lost employee work time, maintain healthy workplaces and strengthen productivity. USHW also provides non-injury occupational health services including job-site analysis, drug and alcohol testing and employment-related physical examinations.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-02-27 Intralign Health

Scottsdale, Arizona, United States

Intralign Health is a specialty healthcare services company offering an integrated suite of services to hospitals and health systems. Intralign’s orthopedic solutions provide data-driven efficiency tools, care-centered design processes and clinical support services to healthcare providers, enabling them to better control the economics and quality of major joint replacements.

Buy -
Mergr

Product

Company

Legal